Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery
2024

Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Drug Discovery

publication 10 minutes Evidence: high

Author Information

Author(s): Oliver L. Symes, Hikaru Ishikura, Callum S. Begg, Juan J. Rojas, Harry A. Speller, Anson M. Cherk, Marco Fang, Domingo Leung, Rosemary A. Croft, Joe I. Higham, Kaiyun Huang, Anna Barnard, Peter Haycock, Andrew J. P. White, Chulho Choi, James A. Bull

Primary Institution: Imperial College London

Hypothesis

Can oxetane and azetidine sulfonyl fluorides be effectively utilized in drug discovery?

Conclusion

The study demonstrates the potential of oxetane and azetidine sulfonyl fluorides to create diverse and novel pharmacophore motifs for drug discovery.

Supporting Evidence

  • Oxetanes and azetidines are valuable in medicinal chemistry due to their unique properties.
  • New synthetic strategies were developed for the preparation of oxetane and azetidine derivatives.
  • Eleven drug analogs were synthesized to demonstrate the utility of the new reagents.
  • The study highlights the compatibility of OSF and ASF reagents with a broad range of nucleophiles.
  • These reagents can be used to create new linker motifs for targeted protein degradation.
  • The research provides new design options for medicinal chemists.
  • OSF and ASF reagents can access novel chemical motifs that may serve as bioisosteres.
  • The findings suggest significant potential for these compounds in drug discovery.

Takeaway

This study shows how certain chemical compounds can help scientists create new medicines by making it easier to combine different chemical parts.

Methodology

The study involved the development and application of oxetane and azetidine sulfonyl fluorides in various chemical reactions to synthesize new drug analogs.

Limitations

The preparation of oxetane and azetidine derivatives can be challenging and may require specific conditions.

Digital Object Identifier (DOI)

10.1021/jacs.4c14164

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication